F.-X. Mahon
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 18
- Chronic Myeloid Leukemia Treatments 17
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
- Genetics 14
- Chronic Lymphocytic Leukemia Research 14
- Co-authors
- Arnaud PigneuxJ.-M. BoironJosy ReiffersGérald MaritC. FabèresC Bilhou-NabéraPascale Cony‐MakhoulMichele Baccarani
- Journals
- Journal of Clinical Oncology (3 papers)Leukemia Research (2 papers)Haematologica (2 papers)Blood (2 papers)Blood Reviews (1 paper)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
F.-X. Mahon
19 papers receiving 399 citations
Peers
Comparison fields: 5 of 46
- Hematology 323
- Genetics 268
- Rheumatology 162
- Oncology 51
- Pathology and Forensic Medicine 29
Countries citing papers authored by F.-X. Mahon
This map shows the geographic impact of F.-X. Mahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.-X. Mahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.-X. Mahon more than expected).
Fields of papers citing papers by F.-X. Mahon
This network shows the impact of papers produced by F.-X. Mahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.-X. Mahon. The network helps show where F.-X. Mahon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F.-X. Mahon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 28 | |
| 3 | 2022 | 1 | |
| 4 | 2016 | 2 | |
| 5 | STOPPING TYROSINE KINASE INHIBITORS IN A VERY LARGE COHORT OF EUROPEAN CHRONIC MYELOID LEUKEMIA PATIENTS: RESULTS OF THE EURO-SKI TRIAL | 2016 | 15 |
| 6 | 2014 | 10 | |
| 7 | 2012 | 31 | |
| 8 | 2011 | 67 | |
| 9 | 2010 | 24 | |
| 10 | 2008 | 2 | |
| 11 | 2003 | 35 | |
| 12 | 2002 | 52 | |
| 13 | [Leukemogenesis and new therapy development: the example of chronic myelogenous leukemia]. | 2001 | 1 |
| 14 | 1998 | 4 | |
| 15 | 1998 | 46 | |
| 16 | 1998 | 47 | |
| 17 | 1996 | 3 | |
| 18 | 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells. | 1995 | 13 |
| 19 | Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction. | 1995 | 28 |
| 20 | 1994 | 5 |
About F.-X. Mahon
F.-X. Mahon is a scholar working on Hematology, Genetics, Rheumatology, Public Health, Environmental and Occupational Health and Pharmacology, having authored 20 papers that have together received 414 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (17 papers), Chronic Lymphocytic Leukemia Research (14 papers), Eosinophilic Disorders and Syndromes (9 papers), Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Click Chemistry and Applications (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (323 citations), Genetics (268 citations), Rheumatology (162 citations), Oncology (51 citations) and Pathology and Forensic Medicine (29 citations). F.-X. Mahon has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Arnaud Pigneux, J.-M. Boiron, Josy Reiffers, Gérald Marit, C. Fabères, C Bilhou-Nabéra, Pascale Cony‐Makhoul, Michele Baccarani, Joëlle Guilhot and Sophie Pueyo. Their work appears in journals such as Journal of Clinical Oncology, Leukemia Research, Haematologica, Blood and Blood Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.